FDA Clears Tumor Profiling Assay that Analyzes 425 Cancer-Related Genes
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
Read MorePosted by CLP Edit Staff | Sep 4, 2025 | Sequencing Systems |
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
Read MorePosted by CLP Edit Staff | Sep 4, 2025 | Analytical Software Systems |
The new platform integrates genomic and epigenomic data in a single long-read sequencing assay, providing high-resolution insights into chromatin structure, gene regulation, and disease mechanisms.
Read MorePosted by CLP Edit Staff | Sep 4, 2025 | Amplification Technologies |
The DNA-based stool screening test is now authorized for marketing through the MHRA, expanding access to non-invasive CRC detection.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Molecular Diagnostic Analyzers |
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Analytical Software Systems |
Mount Sinai researchers develop machine learning approach that analyzes common clinical data to determine penetrance of rare genetic variants.
Read More